NanoViricides Inc
$ 1.55
0.65%
30 Jul - close price
- Market Cap 35,698,800 USD
- Current Price $ 1.55
- High / Low $ 1.59 / 1.53
- Stock P/E N/A
- Book Value 0.42
- EPS -0.43
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.50 %
- ROE -0.90 %
- 52 Week High 2.23
- 52 Week Low 0.85
About
NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. The company is headquartered in Shelton, Connecticut.
Analyst Target Price
$6.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-14 | 2026-02-17 | 2025-11-14 | 2025-09-03 | 2025-05-15 | 2025-02-14 | 2024-11-14 | 2024-09-27 | 2024-05-15 | 2024-02-14 | 2023-10-13 | 2023-08-30 |
| Reported EPS | -0.09 | -0.11 | -0.1 | -0.12 | -0.14 | -0.1391 | -0.228 | -0.19 | -0.16 | -0.18 | -0.17 | -0.3052 |
| Estimated EPS | -0.08 | -0.08 | -0.18 | -0.2 | -0.19 | -0.18 | -0.17 | -0.2 | -0.19 | -0.19 | -0.17 | -0.17 |
| Surprise | -0.01 | -0.03 | 0.08 | 0.08 | 0.05 | 0.0409 | -0.058 | 0.01 | 0.03 | 0.01 | 0 | -0.1352 |
| Surprise Percentage | -12.5% | -37.5% | 44.4444% | 40% | 26.3158% | 22.7222% | -34.1176% | 5% | 15.7895% | 5.2632% | 0% | -79.5294% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NNVC
2026-08-03 16:10:44
NanoViricides, Inc. announced the closing of a $6 million registered direct offering where it sold 3,571,429 shares of common stock at $1.68 per share to a single institutional investor. Concurrently, the company issued Series A and Series B warrants to purchase an additional 3,571,429 shares each. The net proceeds will be used for working capital and general corporate purposes, advancing the company's clinical-stage antiviral drug development.
2026-08-03 03:13:02
NanoViricides, Inc. (NYSE American:NNVC) announced a registered direct offering to a single healthcare institutional investor for 3,571,429 shares of common stock at $1.68 per share, expecting to raise approximately $6 million. Concurrently, the company will issue Series A and Series B warrants to purchase an additional 3,571,429 shares each. The net proceeds will be used for working capital and general corporate purposes.
2026-08-01 14:39:19
NanoViricides, Inc. (NNVC) has announced the closing of a $6 million registered direct offering and a concurrent private placement. The offering involved the sale of 3,571,429 shares of common stock at $1.68 per share to a single healthcare institutional investor. Additionally, the company issued Series A and Series B warrants, with exercise prices of $1.75 and $2.00 respectively, to purchase up to 3,571,429 shares each.
2026-07-31 03:09:49
NanoViricides has announced a registered direct offering of common shares and warrants, expecting to raise approximately US$3.8 million in gross proceeds. The offering includes 2,516,339 common shares, with each warrant exercisable at US$1.75 per share and expiring 5.5 years from issuance. The closing of this offering is targeted for around July 27, 2026.
2026-07-30 10:40:27
NanoViricides successfully completed a registered direct offering, securing approximately $3.8 million in gross proceeds through the sale of common shares and pre-funded and common warrants. The company plans to allocate the net proceeds towards working capital, R&D, clinical trials, and strategic initiatives. Additionally, NanoViricides engaged D. Boral Capital as its exclusive placement agent and implemented 30-day post-closing lock-ups for its CEO and principal stockholder.
2026-07-28 15:13:02
This article from TradingKey provides a revenue breakdown for NanoViricides Inc (NNVC), covering business segments and regional revenue and profit contribution. It states that the relevant data has not yet been disclosed by the company. The article also includes current stock information for NNVC, showing a price of $1.650, an increase of 8.55%, and a market cap of $35.72 million.
